These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9622057)

  • 1. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?
    Zhu BT; Conney AH
    Cancer Res; 1998 Jun; 58(11):2269-77. PubMed ID: 9622057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical hypothesis: hyperhomocysteinemia is a risk factor for estrogen-induced hormonal cancer.
    Zhu BT
    Int J Oncol; 2003 Mar; 22(3):499-508. PubMed ID: 12579301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis.
    Ashburn SP; Han X; Liehr JG
    Mol Pharmacol; 1993 Apr; 43(4):534-41. PubMed ID: 8386306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
    Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
    Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid protects hepatoma cells against metabolic stress-induced cell death.
    Uen YH; Ko PH; Yin PH; Liu TY; Chi CW; Lui WY
    Int J Oncol; 2008 Dec; 33(6):1263-70. PubMed ID: 19020760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C2- and C4-position 17beta-estradiol metabolites and their relation to breast cancer.
    Joubert A; Van Zyl H; Laurens J; Lottering ML
    Biocell; 2009 Dec; 33(3):137-40. PubMed ID: 20067028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct tumor stage-specific inhibitory effects of 2-methoxyestradiol in a breast cancer mouse model associated with Id-1 expression.
    Huh JI; Calvo A; Charles R; Green JE
    Cancer Res; 2006 Apr; 66(7):3495-503. PubMed ID: 16585173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.
    Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S
    Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic deglucuronidation and demethylation of estrogen conjugates as a source of parent estrogens and catecholestrogen metabolites in Syrian hamster kidney, a target organ of estrogen-induced tumorigenesis.
    Zhu BT; Evaristus EN; Antoniak SK; Sarabia SF; Ricci MJ; Liehr JG
    Toxicol Appl Pharmacol; 1996 Jan; 136(1):186-93. PubMed ID: 8560473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens.
    Newbold RR; Liehr JG
    Cancer Res; 2000 Jan; 60(2):235-7. PubMed ID: 10667565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methoxyestradiols mediate the antimitogenic effects of 17beta-estradiol: direct evidence from catechol-O-methyltransferase-knockout mice.
    Zacharia LC; Gogos JA; Karayiorgou M; Jackson EK; Gillespie DG; Barchiesi F; Dubey RK
    Circulation; 2003 Dec; 108(24):2974-8. PubMed ID: 14662705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens.
    Garner CE; Burka LT; Etheridge AE; Matthews HB
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):115-23. PubMed ID: 10637135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenolphthalein metabolite inhibits catechol-O-methyltransferase-mediated metabolism of catechol estrogens: a possible mechanism for carcinogenicity.
    Garner CE; Matthews HB; Burka LT
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):124-31. PubMed ID: 10637136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells.
    Seeger H; Wallwiener D; Kraemer E; Mueck AO
    Maturitas; 2006 Apr; 54(1):72-7. PubMed ID: 16213115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
    Han GZ; Liu ZJ; Shimoi K; Zhu BT
    Cancer Res; 2005 Jan; 65(2):387-93. PubMed ID: 15695378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450-mediated metabolism of estrogens and its regulation in human.
    Tsuchiya Y; Nakajima M; Yokoi T
    Cancer Lett; 2005 Sep; 227(2):115-24. PubMed ID: 16112414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.
    Li KM; Todorovic R; Devanesan P; Higginbotham S; Köfeler H; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
    Carcinogenesis; 2004 Feb; 25(2):289-97. PubMed ID: 14578156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Methoxyestradiol blocks estrogen-induced rat pituitary tumor growth and tumor angiogenesis: possible role of vascular endothelial growth factor.
    Banerjeei SK; Zoubine MN; Sarkar DK; Weston AP; Shah JH; Campbell DR
    Anticancer Res; 2000; 20(4):2641-5. PubMed ID: 10953337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM; Christov K
    Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.